Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-25

Clinical Trial Update: Epividian / AHF: Positive Pathways - HIV Retention in Care

View source ↗

Summary

The clinical trial NCT04147832 evaluating Epividian for HIV retention in care has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epividian

Snippet

Sponsor: Epividian | Conditions: HIV/AIDS | Status: COMPLETED